Convergent immunological solutions to Argentine hemorrhagic fever virus neutralization

Proceedings of the National Academy of Sciences of the United States of America

Volumn 114, Issue 27, 2017, Pages 7031-7036

  Zeltina, Antra ^a   Krumm, Stefanie A ^b   Sahin, Mehmet ^c   Struwe, Weston B ^d   Harlos, Karl ^a   Nunberg, Jack H ^e   Crispin, Max ^d,f   Pinschewer, Daniel D ^c   Doores, Katie J ^b   Bowden, Thomas A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BASEL   (Switzerland)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF MONTANA   (United States)

^f SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Antibody response; Arenavirus; Glycoprotein; Hemorrhagic fever; Structure

Indexed keywords

EPITOPE; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; OD 01; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; GLYCOPROTEIN; PROTEIN BINDING; RECOMBINANT PROTEIN; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANTIBODY RESPONSE; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARGENTINA; ARGENTINE HEMORRHAGIC FEVER; ARTICLE; COMPARATIVE STUDY; CROSS REACTION; ENDEMIC DISEASE; HEK293T CELL LINE; HUMAN; HUMAN CELL; HYDROGEN BOND; JUNIN VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; RECEPTOR BINDING; VIRUS ATTACHMENT; VIRUS NEUTRALIZATION; AMERICAN HEMORRHAGIC FEVER; BINDING SITE; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEK293 CELL LINE; IMMUNE SYSTEM; IMMUNOLOGY; SERODIAGNOSIS; X RAY CRYSTALLOGRAPHY;

ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BINDING SITES; CRYSTALLOGRAPHY, X-RAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; GLYCOPROTEINS; HEK293 CELLS; HEMORRHAGIC FEVER, AMERICAN; HUMANS; IMMUNE SYSTEM; JUNIN VIRUS; NEUTRALIZATION TESTS; PROTEIN BINDING; RECOMBINANT PROTEINS; VIRAL ENVELOPE PROTEINS;

EID: 85021757159     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1702127114     Document Type: Article

References (56)

1. Shao J, Liang Y, Ly H (2015) Human hemorrhagic fever causing arenaviruses: Molecular mechanisms contributing to virus virulence and disease pathogenesis. Pathogens 4:283-306.
2. Radoshitzky SR, et al. (2015) Past, present, and future of arenavirus taxonomy. Arch Virol 160:1851-1874.
3. McLay L, Liang Y, Ly H (2014) Comparative analysis of disease pathogenesis and molecular mechanisms of New World and Old World arenavirus infections. J Gen Virol 95:1-15.
4. Delgado S, et al. (2008) Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia. PLoS Pathog 4:e1000047.
5. Lisieux T, et al. (1994) New arenavirus isolated in Brazil. Lancet 343:391-392.
6. Enserink M (2000) Emerging diseases. New arenavirus blamed for recent deaths in California. Science 289:842-843.
7. García JB, et al. (2000) Genetic diversity of the Junin virus in Argentina: Geographic and temporal patterns. Virology 272:127-136.
8. Gómez RM, et al. (2011) Junín virus. A XXI century update. Microbes Infect 13: 303-311.
9. Geisbert TW, Jahrling PB (2004) Exotic emerging viral diseases: Progress and challenges. Nat Med 10(12, Suppl):S110-S121.
10. Maiztegui JI, Fernandez NJ, de Damilano AJ (1979) Efficacy of immune plasma in treatment of Argentine haemorrhagic fever and association between treatment and a late neurological syndrome. Lancet 2:1216-1217.
11. Maiztegui JI, et al.; AHF Study Group (1998) Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. J Infect Dis 177:277-283.
12. Enria DA, Briggiler AM, Fernandez NJ, Levis SC, Maiztegui JI (1984) Importance of dose of neutralising antibodies in treatment of Argentine haemorrhagic fever with immune plasma. Lancet 2:255-256.
13. York J, Nunberg JH (2016) Myristoylation of the arenavirus envelope glycoprotein stable signal peptide is critical for membrane fusion but dispensable for virion morphogenesis. J Virol 90:8341-8350.
14. Nunberg JH, York J (2012) The curious case of arenavirus entry, and its inhibition. Viruses 4:83-101.
15. Burri DJ, da Palma JR, Kunz S, Pasquato A (2012) Envelope glycoprotein of arenaviruses. Viruses 4:2162-2181.
16. Li S, et al. (2016) Acidic pH-Induced conformations and LAMP1 binding of the Lassa virus glycoprotein spike. PLoS Pathog 12:e1005418.
17. Parsy ML, Harlos K, Huiskonen JT, Bowden TA (2013) Crystal structure of Venezuelan hemorrhagic fever virus fusion glycoprotein reveals a class 1 postfusion architecture with extensive glycosylation. J Virol 87:13070-13075.
18. Crispin M, Zeltina A, Zitzmann N, Bowden TA (2016) Native functionality and therapeutic targeting of arenaviral glycoproteins. Curr Opin Virol 18:70-75.
19. Bowden TA, et al. (2009) Unusual molecular architecture of the machupo virus attachment glycoprotein. J Virol 83:8259-8265.
20. Radoshitzky SR, et al. (2007) Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature 446:92-96.
21. Bowden TA, Jones EY, Stuart DI (2011) Cells under siege: Viral glycoprotein interactions at the cell surface. J Struct Biol 175:120-126.
22. Abraham J, Corbett KD, Farzan M, Choe H, Harrison SC (2010) Structural basis for receptor recognition by New World hemorrhagic fever arenaviruses. Nat Struct Mol Biol 17:438-444.
23. Choe H, Jemielity S, Abraham J, Radoshitzky SR, Farzan M (2011) Transferrin receptor 1 in the zoonosis and pathogenesis of New World hemorrhagic fever arenaviruses. Curr Opin Microbiol 14:476-482.
24. Sanchez A, et al. (1989) Junin virus monoclonal antibodies: Characterization and cross-reactivity with other arenaviruses. J Gen Virol 70:1125-1132.
25. Zeitlin L, et al. (2016) Monoclonal antibody therapy for Junin virus infection. Proc Natl Acad Sci USA 113:4458-4463.
26. Mahmutovic S, et al. (2015) Molecular basis for antibody-mediated neutralization of New World hemorrhagic fever mammarenaviruses. Cell Host Microbe 18:705-713.
27. Martin AC, Thornton JM (1996) Structural families in loops of homologous proteins: Automatic classification, modelling and application to antibodies. J Mol Biol 263: 800-815.
28. Sommerstein R, et al. (2015) Arenavirus glycan shield promotes neutralizing antibody evasion and protracted infection. PLoS Pathog 11:e1005276.
29. Swindells MB, et al. (2017) abYsis: Integrated antibody sequence and structuremanagement, analysis, and prediction. J Mol Biol 429:356-364.
30. Abraham J, et al. (2009) Host-species transferrin receptor 1 orthologs are cellular receptors for nonpathogenic new world clade B arenaviruses. PLoS Pathog 5: E1000358.
31. Radoshitzky SR, et al. (2008) Receptor determinants of zoonotic transmission of New World hemorrhagic fever arenaviruses. Proc Natl Acad Sci USA 105:2664-2669.
32. Scheid JF, et al. (2011) Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding. Science 333:1633-1637.
33. Schmidt AG, et al. (2015) Viral receptor-binding site antibodies with diverse germline origins. Cell 161:1026-1034.
34. Chen Z, et al. (2013) Cross-neutralizing human anti-poliovirus antibodies bind the recognition site for cellular receptor. Proc Natl Acad Sci USA 110:20242-20247.
35. Brouillette RB, Phillips EK, Ayithan N, Maury W (2017) Differences in glycoprotein complex (GPC) receptor binding site accessibility prompt poor cross-reactivity of neutralizing antibodies between closely related arenaviruses. J Virol 91:e01454-16.
36. Robinson JE, et al. (2016) Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits. Nat Commun 7: 11544.
37. Smith K, et al. (2009) Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen. Nat Protoc 4:372-384.
38. Berrow NS, Alderton D, Owens RJ (2009) The precise engineering of expression vectors using high-throughput In-Fusion PCR cloning. Methods Mol Biol 498:75-90.
39. Aricescu AR, Lu W, Jones EY (2006) A time- and cost-efficient system for high-level protein production in mammalian cells. Acta Crystallogr D Biol Crystallogr 62: 1243-1250.
40. Chang VT, et al. (2007) Glycoprotein structural genomics: Solving the glycosylation problem. Structure 3:267-273.
41. Tiller T, et al. (2008) Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. J Immunol Methods 329: 112-124.
42. Walter TS, et al. (2005) A procedure for setting up high-throughput nanolitre crystallization experiments. Crystallization workflow for initial screening, automated storage, imaging and optimization. Acta Crystallogr D Biol Crystallogr 61:651-657.
43. Winter G (2009) xia2: An expert system for macromolecular crystallography data reduction. J Appl Crystallogr 43:186-190.
44. Karplus PA, Diederichs K (2012) Linking crystallographic model and data quality. Science 336:1030-1033.
45. McCoy AJ, et al. (2007) Phaser crystallographic software. J Appl Crystallogr 40: 658-674.
46. Nakayama T, et al. (2015) Structural features of interfacial tyrosine residue in ROBO1 fibronectin domain-antibody complex: Crystallographic, thermodynamic, and molecular dynamic analyses. Protein Sci 24:328-340.
47. Emsley P, Cowtan K (2004) Coot: Model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60:2126-2132.
48. Murshudov GN, et al. (2011) REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr D Biol Crystallogr 67:355-367.
49. Winn MD, Murshudov GN, Papiz MZ (2003) Macromolecular TLS refinement in REFMAC at moderate resolutions. Methods Enzymol 374:300-321.
50. Painter J, Merritt EA (2006) Optimal description of a protein structure in terms of multiple groups undergoing TLS motion. Acta Crystallogr D Biol Crystallogr 62: 439-450.
51. Chen VB, et al. (2010) MolProbity: All-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr 66:12-21.
52. Agirre J, et al. (2015) Privateer: Software for the conformational validation of carbohydrate structures. Nat Struct Mol Biol 22:833-834.
53. Ren J, et al. (2009) DOG 1.0: Illustrator of protein domain structures. Cell Res 19: 271-273.
54. Krissinel E, Henrick K (2007) Inference of macromolecular assemblies from crystalline state. J Mol Biol 372:774-797.
55. Sievers F, et al. (2011) Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol 7:539.
56. Robert X, Gouet P (2014) Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res 42:W320-W324.